首頁 > 市場調查報告書 > 醫療設備

整形外科生物材料

市場調查報告書

商品編碼

1550592

脫鈣骨基質市場：依產品類型、依組織來源、依應用、依最終使用者、按地區

Demineralized Bone Matrix Market, By Product Type, By Tissue Source, By Application, By End User, By Geography

出版日期: 2024年08月21日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球脫礦骨基質（DBM）市場規模為14.1億美元，2024年至2031年複合年成長率為6.2%，預計2031年將達21.5億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	14.1億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測 2024-2031 年複合年成長率：	6.20%	2031年價值預測	21.5億美元

圖：2024 年按地區分類的脫礦骨基質市場佔有率 (%)

全球脫礦骨基質市場在過去幾年中一直穩定成長。脫礦骨基質（DBM）是由同種異體骨去除骨骼中的礦物質成分後所製成的骨生物材料。由於它促進骨形成，因此在牙科和整形外科手術中用作骨移植的替代品。由於創傷、骨折和各種骨骼相關疾病發生率的增加，牙科和整形外科手術數量不斷增加，這是推動全球脫礦骨基質需求的因素之一。此外，人們越來越認知到 DBM 相對於自體骨移植的優勢，例如降低供體部位發病率和易於獲得，進一步推動了市場的成長。然而，移植骨替代物核准的嚴格規定可能會在一定程度上抑制市場。

（市場動態）：。

推動全球脫礦骨基質市場成長的主要因素包括越來越多的老年人口更容易患骨疾病、牙科疾病盛行率的增加、脊椎融合手術和重組手術數量的增加，其中包括DBM 與骨移植相比的優勢。此外，專注於透過各種技術增強 DBM 骨誘導特性的持續研究和開發也為市場參與者創造了新的機會。然而，移植骨替代物核准的嚴格法律規範以及與 DBM 產品相關的高成本是阻礙市場成長的主要挑戰。此外，對合成骨移植等替代骨移植材料的偏好也在一定程度上限制了市場的擴張。

（本次調查的主要特點）

該研究報告對全球脫礦骨基質市場進行了深入分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和復合年成長率（CAGR%）。

它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還涵蓋市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、美敦力、萊特醫療集團、史賽克、強生 (DePuy Synthes)、Zimmer Biomet、Xtant Medical、Hans Biomed 等。對世界主要企業所採取的競爭策略的主要考察。

該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球脫礦骨基質市場的各種策略矩陣，將促進相關人員的決策。

Medtronic plc
Johnson & Johnson（DePuy Synthes）
Zimmer Biomet
Stryker
SeaSpine
Xtant Medical
RTI Surgical
HansBioMed
Arthrex GmbH
Exactech, Inc.
AlloSource
Halma（Novabone）
Institut Straumann AG
Orthofix Holdings, Inc.
Straumann
Synthes
Integra LifeSciences
Musculoskeletal Transplant Foundation（MTF）
Bacterin International
Osiris Therapeutics

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI4550

The Global Demineralized Bone Matrix Market is estimated to be valued at USD 1.41 Billion in 2024 and is expected to reach USD 2.15 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.41 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.20%	2031 Value Projection:	US$ 2.15 Bn

Figure. Demineralized Bone Matrix Market Share (%), By Region 2024

The global demineralized bone matrix market has been growing steadily over the past few years. Demineralized bone matrix (DBM) is an osteobiologic material made from allogeneic bone after removing mineral components from the bone. It is utilized as a bone graft substitute in dental and orthopaedic procedures to stimulate bone formation. Rising number of dental surgeries and orthopaedic procedures due to increasing incidence of trauma injuries, bone fractures and various bone related diseases are some of the factors fueling demand for demineralized bone matrix globally. Moreover, growing awareness about advantages of DBM over autografts such as reduced donor site morbidity and greater availability is further supplementing the market growth. However, stringent regulations for approval of bone graft substitutes may restrain the market to a certain extent.

(Market Dynamics):

The key drivers propelling the growth of the global demineralized bone matrix market include rising geriatric population susceptible to bone disorders, increasing prevalence of dental diseases, growing number of spinal fusion and reconstruction surgeries, and advantages offered by DBM over conventional bone grafts. Additionally, ongoing research and development activities focused on enhancing osteoinductive properties of DBM through various techniques are creating new opportunities for market players. However, stringent regulatory framework for approval of bone graft substitutes and high costs associated with DBM products are some of the major challenges hampering the market growth. Moreover, preference for alternative bone grafting materials such as synthetic bone grafts is also restricting the market expansion to some extent.

(Key features of the study):

This report provides in-depth analysis of the global demineralized bone matrix market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players such as Medtronic, Wright Medical Group, Stryker, J &J (DePuy Synthes), Zimmer Biomet, Xtant Medical, and Hans Biomed

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global demineralized bone matrix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global demineralized bone matrix market.

Detailed Segmentation:

Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Putty
- Gel
- Paste
- Strips/Sheets
- Others (Plugs, Fibers, etc.)
Tissue Source Insights (Revenue, USD Bn, 2019 - 2031)
- Allograft
- Xenograft
Application Insights (Revenue, USD Bn, 2019 - 2031)
- Spinal Fusion
- Trauma
- Foot and Ankle
- Dental
- Other Applications
End user Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Orthopedic Clinics
- Academic and Research Institutes
- Ambulatory Surgical Centers
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic plc
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- SeaSpine
- Xtant Medical
- RTI Surgical
- HansBioMed
- Arthrex GmbH
- Exactech, Inc.
- AlloSource
- Halma (Novabone)
- Institut Straumann AG
- Orthofix Holdings, Inc.
- Straumann
- Synthes
- Integra LifeSciences
- Musculoskeletal Transplant Foundation (MTF)
- Bacterin International
- Osiris Therapeutics

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Demineralized Bone Matrix Market, By Product Type
- Global Demineralized Bone Matrix Market, By Tissue Source
- Global Demineralized Bone Matrix Market, By Application
- Global Demineralized Bone Matrix Market, By End User
- Global Demineralized Bone Matrix Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Demineralized Bone Matrix Market, By Product Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Putty
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Paste
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Strips/Sheets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Plugs, Fibers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Demineralized Bone Matrix Market, By Tissue Source, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Allograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Xenograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Demineralized Bone Matrix Market, By Application, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Spinal Fusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Trauma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Foot and Ankle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Demineralized Bone Matrix Market, By End-User, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Orthopedic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Demineralized Bone Matrix Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa

9. COMPETITIVE LANDSCAPE

Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SeaSpine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xtant Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RTI Surgical
HansBioMed
Arthrex GmbH
Exactech, Inc.
AlloSource
Halma (Novabone)
Institut Straumann AG
Orthofix Holdings, Inc.
Straumann
Synthes
Integra LifeSciences
Musculoskeletal Transplant Foundation (MTF)
Bacterin International
Osiris Therapeutics